Tag: "statins"

How Bias May Be Corrupting The Evidence Base For Statin Drugs

| August 29, 2014 | Comments (0)

The supposed ‘gold standard’ of medical research is the ‘double-blind placebo-controlled study’, in which the outcomes after taking a treatment are compared with those achieve with a placebo. In the ‘best’ trials, neither the study participants nor the investigators know who is taking what until the ‘code is cracked’ and the analyses are done. ‘Blinding’ [...]

Read More

Mainstream In A Divided Camp About Statins

| August 26, 2014 | Comments (0)

Recently, I wrote about Professor Sir Rory Collins, who tried to get the British Medical Journal (BMJ) to retract two papers that were faintly critical of cholesterol-lowering statins. A committee convened by the BMJ to look into this matter found there were no grounds for retraction. This episode centred around the claims made in the [...]

Read More

Time For Mainstream To Rethink Their Approach To Cholesterol Drugs

| August 1, 2014 | Comments (0)

Higher levels of so-called ‘good HDL-cholesterol’ is associated with reduced risk of cardiovascular issues including heart disease and stroke. This finding has led to the widespread view that raising HDL cholesterol levels has benefits for health, particularly with regard to cardiovascular risk. There are three main classes of agents that are known to boost HDL [...]

Read More

Statins Could Affect The Benefits Of Regular Exercise

| July 17, 2014 | Comments (1)

Those keen to optimise their cardiovascular health and reduce their risk of heart attack and stroke may well, in addition to ‘eating right’, take steps to be physically fit. One way exercise (e.g. walking, jogging, cycling) increases our ‘fitness’ is by inducing the production of tiny ‘engines’ in the cells known as mitochondria (my-toe-con-dree-ah). Most [...]

Read More

Statins: Pro-statin Doctors Go On The Offensive

| July 10, 2014 | Comments (3)

I reported recently that a group of doctors, some quite prominent, had expressed concerns about the mooted expansion of the prescription of cholesterol-lowering statins, in the UK. They wrote a letter, reported widely in the press, in which they detailed six major objections to the plan, including the mass-medicalization of millions of healthy individuals, the [...]

Read More